$1.13
-0.06-5.04%
Last update: Nov 9, 8:25 AM
RenovoRx Inc
RNXTNASDAQ
The average analyst price target for RenovoRx is $7.33, 531.9% above the current price. Of 4 analysts, 3 rate it Buy and 1 Hold. Targets range from $3 to $15. The latest change came on Nov 9, 2026, when Ascendiant Capital raised its price target on RenovoRx from $14.50 to $15 and kept a Buy rating.
Price Target Range — 12 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months
